Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Meclizine Dosing for Dizziness

Appropriate Dosing and Administration

  • For acute dizziness, a common starting dose is 25 mg three times daily for 5-7 days, according to Praxis Medical Insights 1

Clinical Considerations

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends that meclizine should not be routinely used as first-line treatment for benign paroxysmal positional vertigo (BPPV), as repositioning maneuvers are more effective 2
  • Vestibular suppressant medications like meclizine are not recommended as definitive primary treatment for BPPV but may be used for short-term management of severe symptoms such as nausea or vomiting, with patients being reassessed within 1 month after initial treatment to confirm symptom resolution 2

Special Populations

  • Consider lower doses in elderly patients or those with hepatic/renal impairment, as recommended by Praxis Medical Insights 1

Alternative Treatments

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends canalith repositioning procedures as the first-line treatment for BPPV rather than vestibular suppressant medications 2

REFERENCES

1

Prochlorperazine for Dizziness: Efficacy and Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

clinical practice guideline: benign paroxysmal positional vertigo. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2008